Volume | 203,097 |
|
|||||
News | - | ||||||
Day High | 1.72 | Low High |
|||||
Day Low | 1.59 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
22nd Century Group Inc | XXII | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.65 | 1.59 | 1.72 | 1.65 | 1.58 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
1,306 | 203,097 | US$ 1.64 | US$ 333,999 | - | 1.45 - 180.912 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:54:44 | 30 | US$ 1.6483 | USD |
22nd Century Group Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
71.8M | 43.78M | - | 32.2M | -150.77M | -3.44 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
22nd Century News
Date | Time | Source | News Article |
---|---|---|---|
2/15/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
2/14/2024 | 15:10 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
2/13/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
1/25/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
1/24/2024 | 15:31 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
1/24/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
1/08/2024 | 19:04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
12/28/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
12/21/2023 | 16:02 | Edgar (US Regulatory) | Form 8-K - Current report |
12/04/2023 | 06:07 | GlobeNewswire Inc. | 22nd Century Secures $3.2 Million to Date in Warrant.. |
12/01/2023 | 16:18 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
11/29/2023 | 09:55 | AllPennyStocks.com | Pharma Stock Up Big After Second Major Announcement This.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XXII Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.68 | 1.97 | 1.52 | 1.76 | 539,775 | -0.0305 | -1.82% |
1 Month | 1.86 | 4.31 | 1.45 | 3.24 | 4,491,898 | -0.2105 | -11.32% |
3 Months | 2.40 | 4.31 | 1.45 | 2.91 | 2,278,259 | -0.7505 | -31.27% |
6 Months | 7.2608 | 8.632 | 1.45 | 3.25 | 1,825,470 | -5.61 | -77.28% |
1 Year | 168.00 | 180.912 | 1.45 | 44.18 | 1,846,722 | -166.35 | -99.02% |
3 Years | 957.60 | 972.00 | 1.45 | 340.43 | 1,924,898 | -955.95 | -99.83% |
5 Years | 957.60 | 972.00 | 1.45 | 340.43 | 1,924,898 | -955.95 | -99.83% |
22nd Century Description
22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others. |